2023 Poster Presentations Coming in December


2022 Poster Presentations

P01: Prometheus™: A Novel Approach for Engineering Manufacturable Humanized Antibodies, Presented by Donmienne L., Absolute Antibody

P02: Advanced Antibody Discovery Workflow to Capture Maximum Repertoire Diversity, Presented by Ryan K., Abveris Antibody

P03: Next-Generation Therapeutic mAb Platform: Development of COVID-19 Broadly Neutralizing Antibodies, Presented by Kevin E., Abwiz Bio, Inc.

P04: Increased Accuracy in Evaluation of CD19 CAR Expression in CAR-T Cell Therapy Quality Control and Clinical Trials, Presented by Nicholas A., ACROBiosystems

P05: High-Quality CD3 Protein Plays Crucial Role in Anti-CD3 Bispecific Antibodies Development, Presented by Nicholas A., ACROBiosystems

P06: Engineering Recombinant Immune Checkpoint Proteins for Antibody Drug Development, Presented by Nicholas A., ACROBiosystems

P08: Advances in Circular Dichroism Spectroscopy Data Acquisition, Presented by Pavel R., Applied Photophysics

P09: Alternatives for Affinity Adsorbent Development for Downstream Bioprocessing, Presented by Bruce D., Astrea Bioseparations US, Inc.

P10: Novel Transposases for Cell-Line Development, Presented by Oren B., ATUM

P11: Implemented Workflows for Model-Based Downstream Process Development, Presented by Thiemo H., Cytiva

P12: Dual Parameter Screening - Two for the Price of One, Presented by Cynthia S., Cytiva

P13: 360-Degree Automated Characterization of AAVs: The Safe Solution for Gene Therapy, Presented by Mays H., Fida Biosystems ApS

P14: Protein Characterization in 3D: Size, Folding and Functional Assessment in a Unified Approach, Presented by Mays H., Fida Biosystems ApS

P15: An Automated Methodology for Assessment of Protein Stability Using Nanograms of Protein, Presented by Mays H., Fida Biosystems ApS

P16: AmMag™ Quatro: Large Scale Automated Plasmid Purification, Presented by Rouba N., GenScript USA, Inc.

P17: Accelerating Bioprocess Workflows with Microfluidic Immunoassay-Based Parallel Impurity Analysis, Presented by Robert D., Gyros Protein Technologies

P18: Characterize mAb Stability as Early as Cell Line Development, Only with the Aura, Presented by Bernardo C., Halo Labs

P19: Automated Purification of 5 mL Lysates Using Dispersive Solid Phase Extraction in Pipettes, Presented by Andrew L., Integrated Micro-Chromatography Systems, Inc. (IMCS)

P20: Human Stem Cell Humanized Mouse Model for In Vivo Evaluation of Bispecific Antibody Efficacy and Drug-Induced Cytokine Release, Presented by Xingtong L., Jackson Laboratories

P21: Mechanisms of Subvisible Particle Formation for Closed-System Transfer Devices (CSTDs) Applied to Protein Biologics, Presented by Christine P., KBI Biopharma

P22: Field-Flow Fractionation (FFF): An Orthogonal Method to SEC/AUC, Particle Investigation and Beyond, Presented by Jing S., Merck & Co., Inc.

P23: Influence of Protein Adsorption on Aggregation in Pre-Filled Syringes, Presented by Saki Y., Osaka University

P24: A Systems Approach Leading to an Integrated and Automated Workflow Solution for Screening of Monoclonal Antibody Hybridomas, Presented by Allan A., PerkinElmer

P25: Rapid Characterization of Antibodies on the LabChip GXII Touch System, Presented by James G., PerkinElmer

P26: High-Speed and High-Precision Fl-Based Cell Counting and Viability Assays Using the Cellaca MX High-Throughput Cell Count, Presented by Henry Q., PerkinElmer

P27: Improving Inter-Instrument Consistency and High Precision for CHO Cell Bioprocessing Using the Cellaca MX High-Throughput Cell Counter, Presented by Henry Q., PerkinElmer

P28: Novel Cell-Based High-Throughput Hybridoma Screening Method Using the Celigo Image Cytometer and Antibody Discovery, Presented by Henry Q., PerkinElmer

P29: Development of AlphaLISA Assays for Quantification and Characterization of Biotherapeutic Proteins and Process Contaminants, Presented by Doug S., PerkinElmer

P30: Improving Transient CHO and HEK-293 Expression Systems with a Powerful Transfection Solution for High Protein Production Yields: FectoPRO®, Presented by Ashlee S., Polyplus-transfection

P31: Next-Generation Transfection Reagent for Large Scale AAV Manufacturing, Presented by Ashlee S., Polyplus-transfection

P32: Meet BeatBox: PreOmics Revolutionize Tissue Homogenization, Presented by Zuzana D., PreOmics GmbH

P33: Quantitative PBMC ADCC Bioassay and ADCC Reporter Bioassays for Immunotherapy and SARS-CoV-2 Monoclonal Antibody Development, Presented by Steven E., Promega Corporation

P34: Characterization of Maurice™ CE-SDS PLUS For USP <129> Suitability, Presented by Hadi M., ProteinSimple, a Bio-Techne Brand

P35: MMS Evaluation of HOS for IgG Samples Spiked with BSA, Presented by David S., RedShift Bio

P36: A Multiplex Epitope Measurement Tool to Understand SARS-CoV-2 Antibody Response, Presented by Chris D., Robust Diagnostics, LLC

P37: Identification of Novel Regulatory Factors for B7-H3 in Breast Cancer Stem Cell Based on DNA-Affinity Purification Mass Spectrometry, Presented by Yuri S., Seoul National University

P38: MabPairs: A Novel Approach to the Production of a Bi-Functional Antibody Product, Presented by Ronald S., Sound Biologics

P39: Size, Shape, Count and Identification of Contaminants Using Total Holographic Characterization, Presented by Laura P., Spheryx, Inc.

P40: Development of Potent, Selective Surrogate WNT Molecules and Their Application in Tissue Regeneration, Presented by Hui C., Surrozen, Inc.

P42: Viral Clearance Strategy for POROS Hydrophobic Interaction Chromatography, Presented by Allyson D., Thermo Fisher Scientific

P43: Accelerating Advancement in Gene Therapy by Improving Downstream Purification of Viral Vectors, Presented by Cole D., Thermo Fisher Scientific

P44: Enabling Custom Solutions for Downstream Processing, Presented by Cole D., Thermo Fisher Scientific

P45: Accelerating Antibody Drug Development with Subdomain-Specific Affinity Ligands, Presented by Summer S., Thermo Fisher Scientific

P46: Miniaturized Devices for Development and Optimization of Protein Precipitation and Tangential Flow Filtration, Presented by Maria del Carme P., University of Natural Resources and Life Sciences/Austrian Centre of Industrial Biotechnology (acib)

P47: CyDisCo Production of Functional Recombinant SARS-CoV-2 Spike Receptor Binding Domain, Presented by Janani P., University of Nebraska Medical Center

P48: Rapid and High-Throughput IgG Quantification in Cell Culture Supernatant, Presented by Brian M., ValitaCell

P49: ADC Therapeutic Window Enhancement Based on the AJICAP, Chemical Site-Specific Conjugation Platform, Presented by Tomohiro F., Ajinomoto Co., Inc.

P50: Corynex®: Suitable Protein Expression System for Antibody Mimetics Using Corynebacterium glutamicum, Presented by Yoshihiko M., Ajinomoto Co., Inc.

P51: Degraded Polysorbates Still Function as Surfactants, Presented by Yuka K., Daiichi Sankyo Co., Ltd.

P52: Biophysical Characterization and Developability Workflows in Biotherapeutics Discovery, Presented by Teresa B., Flow Eighteen38

P53: Fully Automated High Throughput Purification Platform for Small Scale Expression in E.coli, Presented by Jane Z., GlaxoSmithKline

P54: Three-Dimensional Homodyne Light Detection(3D-HLD): High-Throughput Analytical Method for the Size Distribution of Submicron-Sized Protein Aggregates, Presented by Kentaro O., Hitachi High-Tech Corporation

P55: Fast and Cost-Effective Purification of Bispecific Antibodies Using a Semi-Automated Magnetic Beads Process in Conjunction with the AKTA Platform to Enable Milligram to Gram Scale Up in Protein Production, Presented by Olivier B., Ichnos Sciences Biotherapeutics S.A.

P56: Generation of Transposase-Based Stable Pools at the Discovery Stage for the Production of Bispecific Therapeutic Antibodies, Presented by Andreas R., Ichnos Sciences Biotherapeutics S.A.

P57: A Predictive Toolbox for Stability Assessment of Biologics Mixing in Drug Product Manufacturing, Presented by Robert K., Merck & Co., Inc.

P58: Characterisation of Adeno Associated Virus Vectors with Liquid Chromatography, Presented by Dennis A., Novo Nordisk A/S

P59: A Drug Development Platform for Protein Biologics that Integrates Production, Developability Assessment, Kinetic Profiling and High Resolution Cryo-EM and X-Ray Structural Determination, Presented by Stephan K., Proteros Biostructures GmbH

P60: A New Convenient Tool to Analyse Protein Glycosylation Based on FT-IR Spectroscopy, Presented by Allison D., Spectralys Biotech

P61: The Conformational scFv Antibody NUsc1 Binds to a Specific Subpopulation of Toxic Beta-Amyloid Oligomers and Neutralizes Neurotoxicity In Vitro, Presented by Nathalia P., University of Sao Paulo

P62: A New Vector for Expression of TwinStrep Maltose Binding Protein Tagged Proteins, Presented by Simon M., Leidos Biomedical Research, Inc.

P63: Therapeutic Bispecific Antibody Against SARS-CoV-2 and Its MutantsPresented by Catherine L., Sanyou Biopharmaceuticals, Co. Ltd.